1. Home
  2. CVKD vs MRIN Comparison

CVKD vs MRIN Comparison

Compare CVKD & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • MRIN
  • Stock Information
  • Founded
  • CVKD 2022
  • MRIN 2006
  • Country
  • CVKD United States
  • MRIN United States
  • Employees
  • CVKD N/A
  • MRIN N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • MRIN EDP Services
  • Sector
  • CVKD Health Care
  • MRIN Technology
  • Exchange
  • CVKD Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • CVKD 6.9M
  • MRIN 7.6M
  • IPO Year
  • CVKD 2023
  • MRIN 2013
  • Fundamental
  • Price
  • CVKD $12.00
  • MRIN $2.20
  • Analyst Decision
  • CVKD Strong Buy
  • MRIN
  • Analyst Count
  • CVKD 2
  • MRIN 0
  • Target Price
  • CVKD $52.50
  • MRIN N/A
  • AVG Volume (30 Days)
  • CVKD 44.9K
  • MRIN 17.4K
  • Earning Date
  • CVKD 11-08-2024
  • MRIN 10-31-2024
  • Dividend Yield
  • CVKD N/A
  • MRIN N/A
  • EPS Growth
  • CVKD N/A
  • MRIN N/A
  • EPS
  • CVKD N/A
  • MRIN N/A
  • Revenue
  • CVKD N/A
  • MRIN $16,864,000.00
  • Revenue This Year
  • CVKD N/A
  • MRIN N/A
  • Revenue Next Year
  • CVKD N/A
  • MRIN N/A
  • P/E Ratio
  • CVKD N/A
  • MRIN N/A
  • Revenue Growth
  • CVKD N/A
  • MRIN N/A
  • 52 Week Low
  • CVKD $5.40
  • MRIN $1.44
  • 52 Week High
  • CVKD $32.55
  • MRIN $5.46
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 55.95
  • MRIN 43.21
  • Support Level
  • CVKD $11.00
  • MRIN $2.14
  • Resistance Level
  • CVKD $15.37
  • MRIN $2.23
  • Average True Range (ATR)
  • CVKD 1.43
  • MRIN 0.07
  • MACD
  • CVKD -0.16
  • MRIN -0.01
  • Stochastic Oscillator
  • CVKD 37.26
  • MRIN 29.63

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: